Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tissue Inhibitor of Metalloproteinases 2 Level Predicts Acute Kidney Injury in Patients Undergoing Cardiac Surgery

NCT06871826 is registered in ClinicalTrials.gov with Wuhan University as lead sponsor.

NCT NCT06871826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06871826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tissue Inhibitor of Metalloproteinases 2 Level Predicts Acute Kidney Injury in Patients Undergoing Cardiac Surgery
Lead sponsor
Wuhan University
Phase
Phase 1/2
Overall status
Completed
Start date
July 22, 2023
Completion date
January 25, 2025
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, extracorporeal circulation; complications, surgery